Glaukos Corp. Company Profile (NYSE:GKOS)

About Glaukos Corp.

Glaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring approximately one millimeter long and approximately 0.33 millimeter wide. MIGS procedures involve the insertion of a micro-scale device from within the eye's anterior chamber through a corneal incision. The Company's micro-scale injectable therapies include pipeline products, such as the iStent Inject, the iStent Supra and iDose. The iStent Inject includes approximately two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is an implant that is designed to provide a sustained release of a prostaglandin drug to lower intraocular pressure in glaucoma patients.

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Instruments & Supplies
Sub-Industry: N/A
Exchange: NYSE
Symbol: GKOS
CUSIP:

Key Metrics:

Previous Close: $39.15
50 Day Moving Average: $32.98
200 Day Moving Average: $26.34
52-Week Range: $33,024,000.00 - $14.25
Trailing P/E Ratio: N/A
Foreward P/E Ratio: 170.22
P/E Growth: 0.00
Market Cap: $1.29B
Outstanding Shares: 33,024,000
Beta: 1.39

Profitability:

Net Margins: -1.23%
Return on Equity: -1.14%
Return on Assets: -0.94%

Debt:

Current Ratio: 6.01%
Quick Ratio: 5.72%

Additional Links:

Companies Related to Glaukos Corp.:

Consensus Ratings for Glaukos Corp. (NYSE:GKOS) (?)

Ratings Breakdown:	1 Hold Rating, 5 Buy Ratings
Consensus Rating:	Buy (Score: 2.83)
Consensus Price Target:	$38.00 (2.94% downside)

Analysts' Ratings History for Glaukos Corp. (NYSE:GKOS)

Show:

Date	Firm	Action	Rating	Price Target
9/25/2016	Cantor Fitzgerald	Reiterated Rating	Buy	$41.00
8/2/2016	Roth Capital	Boost Price Target	Buy	$36.50 -> $41.00
8/2/2016	Piper Jaffray Cos.	Boost Price Target		$42.00
4/8/2016	Stifel Nicolaus	Initiated Coverage	Hold
3/2/2016	JPMorgan Chase & Co.	Lower Price Target	Overweight	$32.00 -> $28.00
11/19/2015	William Blair	Reiterated Rating	Outperform
8/27/2015	Goldman Sachs Group Inc.	Lower Price Target		$33.00 -> $32.00
7/20/2015	Bank of America Corp.	Initiated Coverage	Buy	$37.00
7/20/2015	Canaccord Genuity	Initiated Coverage	Buy	$35.00

(Data available from 9/25/2014 forward)

Earnings History for Glaukos Corp. (NYSE:GKOS)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/8/2016
8/1/2016	Q216	($0.04)	$0.06	$24.45 million	$28.60 million	View	N/A
5/3/2016	Q116	($0.15)	$0.03	$18.77 million	$23.10 million	View	N/A
3/1/2016	Q415	($0.13)	($0.07)	$20.07 million	$20.28 million	View	N/A
11/10/2015	Q315	($0.17)	($0.07)	$17.93 million	$19.00 million	View	Listen

(Data available from 1/1/2011 forward)

Earnings Estimates for Glaukos Corp. (NYSE:GKOS)

Current Year EPS Consensus Estimate: $0.10 EPS
Next Year EPS Consensus Estimate: $0.23 EPS

Dividend History for Glaukos Corp. (NYSE:GKOS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Glaukos Corp. (NYSE:GKOS)

Insider Ownership Percentage: 36.80%
Institutional Ownership Percentage: 71.91%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/12/2016	Jonathan Silverstein	Director	Sell	292,938	$33.69	$9,869,081.22
8/3/2016	Orbimed Advisors Llc	Director	Sell	425,000	$30.59	$13,000,750.00
7/27/2016	Richard L Harrison	CFO	Sell	10,000	$35.01	$350,100.00
7/13/2016	Thomas William Burns	CEO	Sell	162,254	$30.07	$4,878,977.78
7/12/2016	Richard L Harrison	CFO	Sell	5,700	$30.00	$171,000.00
6/20/2016	Richard L Harrison	CFO	Sell	4,300	$30.00	$129,000.00
6/20/2016	Thomas William Burns	CEO	Sell	7,997	$30.00	$239,910.00
6/15/2016	Chris M Calcaterra	Insider	Sell	45,464	$28.46	$1,293,905.44
6/6/2016	Thomas William Burns	CEO	Sell	24,578	$25.16	$618,382.48
6/3/2016	Thomas William Burns	CEO	Sell	422	$25.00	$10,550.00
6/1/2016	Thomas William Burns	CEO	Sell	25,000	$23.90	$597,500.00
5/25/2016	Thomas William Burns	CEO	Sell	300	$25.00	$7,500.00
5/4/2016	Chris M Calcaterra	Insider	Sell	74,536	$24.40	$1,818,678.40
5/4/2016	Richard L Harrison	CFO	Sell	30,000	$24.59	$737,700.00
5/4/2016	Thomas William Burns	CEO	Sell	36,700	$24.67	$905,389.00
3/4/2016	Aimee S Weisner	Director	Buy	2,500	$16.03	$40,075.00
2/25/2016	Montreux Equity Partners Iv Lp	Major Shareholder	Sell	70,000	$16.16	$1,131,200.00
12/31/2015	Richard L Harrison	CFO	Buy	1,388	$15.30	$21,236.40
11/12/2015	Aimee S Weisner	Director	Buy	2,500	$21.83	$54,575.00

(Data available from 1/1/2013 forward)

Latest Headlines for Glaukos Corp. (NYSE:GKOS)

Date	Headline
	Glaukos Corporation (GKOS): Durable Efficacy Data in iStent Study - Cantor (NYSE:GKOS) www.streetinsider.com - September 24 at 4:55 PM
	Glaukos Corporation (GKOS): Durable Efficacy Data in iStent Study - Cantor - StreetInsider.com (NYSE:GKOS) www.streetinsider.com - September 23 at 4:55 PM
	Upcoming Earnings Report: Glaukos Corporation (NYSE:GKOS) - The Voice Registrar (NYSE:GKOS) voiceregistrar.com - September 23 at 10:12 AM
	What is the Street Saying About Glaukos Corp (NYSE:GKOS)? - Frisco Fastball (NYSE:GKOS) friscofastball.com - September 22 at 5:18 PM
	Glaukos Corp (NYSE:GKOS) Ratings in Focus - Stocks Daily (NYSE:GKOS) www.stocksdaily.net - September 22 at 5:18 PM
	International Study Shows Favorable 3-Year Results of 2 Glaukos iStent® Trabecular Micro-Bypass Stents as Initial Treatment for Naïve Glaucoma (NYSE:GKOS) www.publicnow.com - September 22 at 5:18 PM
	Glaukos Corp (NYSE:GKOS) Ratings in Focus (NYSE:GKOS) www.stocksdaily.net - September 21 at 5:43 PM
	Glaukos Corp (GKOS) CEO Sells $618382.48 in Stock - DailyQuint (NYSE:GKOS) dailyquint.com - September 21 at 5:43 PM
	Damage done to stocks means investors need to hit ‘pause’ (NYSE:GKOS) www.marketwatch.com - September 17 at 9:54 AM
	Glaukos Hits a 52-Week High on Positive Estimate Revisions (NYSE:GKOS) finance.yahoo.com - September 16 at 5:05 PM
	Stocks Fall But Nasdaq Up 2% For The Week; Apple, Glaukos Finish Strong (NYSE:GKOS) www.investors.com - September 16 at 5:05 PM
	Glaukos Corporation Common Stoc (GKOS) Reaches New 52-Week High - Finance Daily (NYSE:GKOS) www.fidaily.com - September 15 at 5:37 PM
	Damage done to stocks means investors need to hit 'pause' - MarketWatch (NYSE:GKOS) www.marketwatch.com - September 15 at 5:37 PM
	ETF’s with exposure to Glaukos Corp. : September 14, 2016 (NYSE:GKOS) www.capitalcube.com - September 14 at 5:19 PM
	ETF’s with exposure to Glaukos Corp. : September 14, 2016 (NYSE:GKOS) www.capitalcube.com - September 14 at 5:19 PM
	To Beat Glaucoma, This Company Thrives By Putting A Stick In Your Eye (NYSE:GKOS) www.investors.com - September 9 at 5:02 PM
	Glaukos Corp. breached its 50 day moving average in a Bullish Manner : GKOS-US : September 9, 2016 (NYSE:GKOS) www.capitalcube.com - September 9 at 9:59 AM
	Eye Surgery Or Drops? Glaukos Is Persuading People To Take Option 1 (NYSE:GKOS) www.investors.com - September 9 at 9:59 AM
	Placing Glaukos Corp (NYSE:GKOS) Shares Under the Microscope - Post News (NYSE:GKOS) www.kentuckypostnews.com - September 8 at 9:03 AM
	Steering Attention Towards Earnings; Analysts Weigh in on Glaukos Corp (NYSE:GKOS) Stock - Frisco Fastball (NYSE:GKOS) friscofastball.com - September 8 at 9:03 AM
	Upcoming Earnings Report: Glaukos Corporation (NYSE:GKOS ... - The Voice Registrar (NYSE:GKOS) voiceregistrar.com - September 8 at 9:03 AM
	Multiple Surgeons to Present Clinical Data Regarding Glaukos Glaucoma Devices at 2016 European Society of Cataract and Refractive Surgeons Congress (NYSE:GKOS) www.publicnow.com - September 6 at 9:58 AM
	Glaukos Announces Participation in Baird Healthcare Conference (NYSE:GKOS) finance.yahoo.com - August 24 at 5:06 PM
	ETF’s with exposure to Glaukos Corp. : August 23, 2016 (NYSE:GKOS) www.capitalcube.com - August 23 at 5:23 PM
	Glaukos Corp. breached its 50 day moving average in a Bearish Manner : GKOS-US : August 22, 2016 (NYSE:GKOS) www.capitalcube.com - August 22 at 9:52 AM
	Glaukos : $15 Target Price If More Insurers Change Reimbursements (NYSE:GKOS) www.4-traders.com - August 21 at 9:38 AM
	Glaukos: $15 Target Price If More Insurers Change Reimbursements (NYSE:GKOS) seekingalpha.com - August 20 at 9:27 AM
	Glaukos Corporation Common Stoc (NYSE:GKOS) Trading Up – Insiders Selling, Short Interest Growing (NYSE:GKOS) www.fidaily.com - August 13 at 8:08 AM
	GLAUKOS CORP Financials (NYSE:GKOS) finance.yahoo.com - August 12 at 5:16 PM
	Glaukos Corporation (GKOS) - Medical Equipment - Deals and Alliances Profile - New Report Available (NYSE:GKOS) www.live-pr.com - August 11 at 5:26 PM
	ETF’s with exposure to Glaukos Corp. : August 11, 2016 (NYSE:GKOS) www.capitalcube.com - August 11 at 5:26 PM
	Istar Flies Towards Next-Gen Glaucoma Surgery Device (NYSE:GKOS) seekingalpha.com - August 9 at 4:00 PM
	Glaukos Corp. :GKOS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NYSE:GKOS) www.capitalcube.com - August 9 at 4:00 PM
	Gilder Gagnon Howe Co buys $37566536 stake in Glaukos Corp (GKOS) - Trade Calls (NYSE:GKOS) www.tradecalls.org - August 5 at 5:21 PM
	Traders Recap: TD Ameritrade Holding Corp.(NASDAQ:AMTD), Glaukos Corp(NYSE:GKOS) - NYSE Journal (press release) (NYSE:GKOS) stockznews.com - August 4 at 8:09 AM
	Analyst Rating Update on Glaukos Corporation (GKOS) - Trade Calls (NYSE:GKOS) www.tradecalls.org - August 4 at 8:09 AM
	Glaukos raises guidance after Street-beating Q2 (NYSE:GKOS) www.massdevice.com - August 2 at 5:29 PM
	Roth Capital announced (NYSE:GKOS) Glaukos Corporation, bumping up its price target to $41 earlier today (NYSE:GKOS) breakingfinancenews.com - August 2 at 5:29 PM
	Edited Transcript of GKOS earnings conference call or presentation 1-Aug-16 8:30pm GMT (NYSE:GKOS) finance.yahoo.com - August 2 at 10:02 AM
	Glaukos beats 2Q profit forecasts (NYSE:GKOS) sg.finance.yahoo.com - August 1 at 5:08 PM
	Glaukos Corporation Announces Second Quarter 2016 Financial Results (NYSE:GKOS) www.publicnow.com - August 1 at 5:08 PM
	Q2 2016 Glaukos Corp Earnings Release - After Market Close (NYSE:GKOS) biz.yahoo.com - August 1 at 7:07 AM
	How Analysts Feel About Glaukos Corp (NYSE:GKOS)? - Consumer Eagle (NYSE:GKOS) www.consumereagle.com - July 22 at 5:08 PM
	Glaukos Corp Just Reaches 52-Week High? - Consumer Eagle (NYSE:GKOS) www.consumereagle.com - July 22 at 8:06 AM
	Earnings Focus and Crowd Sourced Sentiment Review for Glaukos Corp (NYSE:GKOS) - TGP (NYSE:GKOS) telanaganapress.com - July 21 at 8:47 AM
	Stock Touching Overbought Territory: Glaukos Corporation (NYSE:GKOS) - Press Telegraph (NYSE:GKOS) presstelegraph.com - July 20 at 6:37 PM
	Equity Roundup: Stock Performance Focus on Glaukos Corp (NYSE:GKOS) - Press Telegraph (NYSE:GKOS) presstelegraph.com - July 20 at 8:05 AM
	Glaukos Corp (NYSE:GKOS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NYSE:GKOS) www.engelwooddaily.com - July 20 at 8:05 AM
	Glaukos Corporation to Release Second Quarter 2016 Financial Results after Market Close on August 1 (NYSE:GKOS) finance.yahoo.com - July 18 at 4:30 PM
	Stock in Positive Territory for the Quarter: Glaukos Corporation (NYSE:GKOS) - Engelwood Daily (NYSE:GKOS) www.engelwooddaily.com - July 18 at 10:24 AM